Author:
Gonzalez Sarah,Mora Hurtado Arielle Carolina,Syder Nicole,Quarshie Claudia,Ghanshani Raveena,Rodman Jack,Elbuluk Nada
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Rostami Mogaddam M, Iranparvar Alamdari M, Maleki N, Safavi Ardabili N, Abedkouhi S. Evaluation of autoimmune thyroid disease in melasma. J Cosmet Dermatol. Jun 2015;14(2):167 − 71. doi:10.1111/jocd.12138
2. Kheradmand M, Afshari M, Damiani G, Abediankenari S, Moosazadeh M. Melasma and thyroid disorders: a systematic review and meta-analysis. Int J Dermatol 2019;58(11):1231–1238. doi:10.1111/ijd.14497
3. Karn D, Kc S, Timalsina M. Lichen Planus Pigmentosus: A study for association of Thyroid Dysfunction. Kathmandu Univ Med J 2016;14(53):36–40. Available from: https://pubmed.ncbi.nlm.nih.gov/27892439/
4. Atefi N, Behrangi E, Nasiripour S, et al. A double blind randomized trial of efficacy and safety of 5% methimazole versus 2% hydroquinone in patients with melasma. Journal of Skin and Stem Cell. 2017;4(2). https://doi.org/10.5812/jssc.62113
5. Malek J, Chedraoui A, Nikolic D, Barouti N, Ghosn S, Abbas O. Successful treatment of hydroquinone-resistant melasma using topical methimazole. Dermatol Ther. Jan-Feb 2013;26(1):69–72. doi:10.1111/j.1529-8019.2012.01540.x